Indian pharma companies' sales to rise after resilience in FY21: Fitch Ratings
Fitch expects sales of drugs used to treat acute medical conditions and elective procedures to continue to recover in FY22.
Also Know...
Search This Blog
- January 2024(67)
- December 2023(82)
- November 2023(96)
- October 2023(104)
- September 2023(116)
- August 2023(113)
- July 2023(99)
- June 2023(99)
- May 2023(99)
- April 2023(97)
- March 2023(109)
- February 2023(67)
- January 2023(51)
- December 2022(55)
- November 2022(39)
- October 2022(26)
- September 2022(45)
- August 2022(36)
- July 2022(43)
- June 2022(50)
- May 2022(36)
- April 2022(42)
- March 2022(50)
- February 2022(45)
- January 2022(93)
- December 2021(323)
- November 2021(620)
- October 2021(600)
- September 2021(607)
- August 2021(666)
- July 2021(653)
- June 2021(636)
- May 2021(658)
- April 2021(619)
- March 2021(663)
- February 2021(205)
- January 2021(45)
- December 2020(59)
Popular
Recents
[getWidget results='3' label='recent' type='list']
Comments
[getWidget results='3' label='comments' type='list']
HR Leadership
[getWidget results='3' label='HR-Leadership' type='list']
0 Comments
Post a Comment